Influence of P-glycoprotein, transfer clearances, and drug binding on intestinal metabolism in Caco-2 cell monolayers or membrane preparations: A theoretical analysis

被引:28
作者
Tam, D [1 ]
Sun, HD [1 ]
Pang, KS [1 ]
机构
[1] Univ Toronto, Fac Pharm, Dept Pharmaceut Sci, Toronto, ON M5S 2S2, Canada
关键词
D O I
10.1124/dmd.31.10.1214
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Studies on the Caco-2 cell monolayer system that contained cytochrome P450 and P-glycoprotein activities had advanced the theory that increased intestinal metabolism resulted with increased drug efflux due to an increase in mean residence time (MRT) in the system. To confirm or refute the claim, we developed compartmental models to study the effects of intestinal secretion on the MRT and rates of metabolism under first-order and nonlinear conditions. The theoretical examinations showed that under first-order conditions, intestinal secretion increased the MRT of drug in all compartments but failed to increase the rate of metabolite formation or the total amount of metabolite formed. Instead, reduced metabolic rates arose with increased efflux from cell, either into the apical or the basolateral compartment. By contrast, under saturable metabolic conditions, there were some conditions found whereby rates of metabolism increased with intestinal secretion and rapid reabsorption, albeit the total amount of metabolite formed eventually equaled the administered dose. Intestinal secretion failed to induce higher rates of metabolism for other conditions (saturable cellular binding, cellular efflux, or cell entry). With saturation of metabolic enzymes, drug efflux brought about desaturation, and, upon rapid recovery of drug into the cellular compartment, higher rates of metabolite formation were attained. The simulation study showed that, under first-order conditions, intestinal secretion reduced the rate of metabolism even though the MRT was prolonged within the cell preparation. With nonlinear metabolism, however, instances may exist whereby higher rates of metabolism would result with secretion.
引用
收藏
页码:1214 / 1226
页数:13
相关论文
共 40 条
[1]   A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma - Continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a p-glycoprotein antagonist [J].
Abraham, J ;
Bakke, S ;
Rutt, A ;
Meadows, B ;
Merino, M ;
Alexander, R ;
Schrump, D ;
Bartlett, D ;
Choyke, P ;
Robey, R ;
Hung, E ;
Steinberg, SM ;
Bates, S ;
Fojo, T .
CANCER, 2002, 94 (09) :2333-2343
[2]  
Carreño-Gómez B, 2000, ANTICANCER RES, V20, P3157
[3]   Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells [J].
Cavet, ME ;
West, M ;
Simmons, NL .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) :1389-1396
[4]   APPLICATION OF MEAN RESIDENCE-TIME CONCEPTS TO PHARMACOKINETIC SYSTEMS WITH NONINSTANTANEOUS INPUT AND NONLINEAR ELIMINATION [J].
CHENG, HY ;
JUSKO, WJ .
PHARMACEUTICAL RESEARCH, 1989, 6 (01) :4-12
[5]   Phase I study of infusional paclitaxel in combination with the P-glycoprotein antagonist PSC 833 [J].
Chico, I ;
Kang, MH ;
Bergan, R ;
Abraham, J ;
Bakke, S ;
Meadows, B ;
Rutt, A ;
Robey, R ;
Choyke, P ;
Merino, M ;
Goldspiel, B ;
Smith, T ;
Steinberg, S ;
Figg, WD ;
Fojo, T ;
Bates, S .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) :832-842
[6]  
Cong D, 2000, DRUG METAB DISPOS, V28, P224
[7]   Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4 [J].
Cummins, CL ;
Jacobsen, W ;
Benet, LZ .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03) :1036-1045
[8]   Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodium butyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate [J].
Cummins, CL ;
Mangravite, LM ;
Benet, LZ .
PHARMACEUTICAL RESEARCH, 2001, 18 (08) :1102-1109
[9]   LOCALIZATION AND CHARACTERIZATION OF DRUG-METABOLIZING-ENZYMES ALONG THE VILLUS-CRYPT SURFACE OF THE RAT SMALL-INTESTINE .2. CONJUGASES [J].
DUBEY, RK ;
SINGH, J .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (02) :177-184
[10]  
FIDDIANGREEN RG, 1975, AM J PHYSIOL, V229, P1641